{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for nonoxynol root_notes_@count in root_notes_@count (approximate match)
Status:
Possibly Marketed Outside US
Source:
NDA022445
(1993)
Source URL:
First approved in 1993
Source:
NDA022445
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA077584
(2010)
Source URL:
First approved in 1986
Source:
NDA019258
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA215609
(1971)
Source URL:
First approved in 1971
Source:
ANDA215609
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Canada:MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Class:
POLYMER
Status:
US Approved Rx
(1996)
Source:
NDA020248
(1996)
Source URL:
First approved in 1975
Source:
INTRALIPID 10% by FRESENIUS
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved OTC
Source:
21 CFR 347.10(l) skin protectant mineral oil
Source URL:
First marketed in 1921
Source:
Liquid Petrolatum U.S.P.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04431934: Not Applicable Interventional Unknown status CARRIER STATE
(2020)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:pariglasgene brecaparvovec [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:inlezifigene civaparvovec [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE
